• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    The present invention relates to improved methods for probing of specific nucleic acids using circularizable probes designed such that they report the presence of a target sequence by allowing a detectable moiety to remain bound if and only if the probe has been cyclized in a target-dependent linking reaction. The invention may be used for distinction between sequence specific varations of nucleic acids.
    公开号:US20010007742A1
    申请号:US09/171,935
    申请日:1997-04-30
    公开日:2001-07-12
    发明作者:Ulf Landergren
    申请人:Ulf Landergren；
    IPC主号:C12Q1-6823
    专利说明:
    [0001] The present invention relates to improved methods for probing of specific nucleic acids. More specifically, the invention relates to a method of detecting specific nucleic acid sequences as well as probes and detecting kits therefor. [0001] BACKGROUND OF THE INVENTION
    [0002] Detection of unique target sequences in the complexity of the human genome requires highly specific detection reagents. This form of gene detection permits target sequence variants to be screened for and it represents one of the most important modalities of gene analysis. The hybridization of single oligonucleotides in general does not afford the requisit specificity, while the combination of two probes such as in PCR (polymerase chain reaction) or OLA (oligonucleotide ligation assay) allows specific detection of unique target sequences. [0002]
    [0003] In situations where many different target sequences are investigated together in a sample by techniques such as PCR or OLA, the risk of “crosstalk” between noncognate pairs of probes, giving rise to false detection signals, increases exponentially with multiplexing. [0003]
    [0004] WO 95/22623 discloses a probe designed to be circularized in the presence of a target sequence and caused to close around the target-containing nucleic acid strand such that the cyclic probe will interlock with and thereby be efficiently linked to the target nucleic acid to be detected. Because of the helical nature of double-stranded nucleic acids, such as DNA, circularized probes will be wound around the target strand, topologically connecting probes to target molecules through catenation, in a manner similar to a padlock. Such covalent catenation of probe molecules to target sequences results in the formation of a hybrid that resists extreme washing conditions, serving to reduce non-specific signals in genetic assays. Any probes hybridizing in a non-specific manner may therefore be removed by subjecting the target to non-hybridizing conditions and/or exonuclease activity. Provided that the circular probe is properly detectable, such as by being suitably labelled, it may then be detected to indicate the presence of the target molecule. [0004]
    [0005] In an assay based on such circularizable probes only intra-molecular reactions give rise to a signal, thereby greatly improving the potential for multiplexing. [0005] SUMMARY OF THE INVENTION
    [0006] The present invention relates to improved methods of detecting specific nucleic acid sequences by means of circularizable probes as well as detecting kits and probes therefor giving considerable advantages in specificity, noise reduction and kinetics compared to prior art. [0006]
    [0007] According to the invention, the circularizable probes are designed such that they report the presence of a target sequence by allowing a detectable moiety to remain bound if and only if the probe has been cyclized in a target-dependent linking reaction. [0007]
    [0008] Thus, in a first aspect, the invention provides a method of detecting a target nucleic acid sequence in a sample by contacting the sample with a detectable probe to hybridize the probe to the target sequence, and detecting the hybridized probe, said probe (below called padlock probe) having two free nucleic acid end parts which are at least partially complementary to and capable of hybridizing to two at least substantially neighbouring regions of the target sequence. The method comprises the following steps: a) hybridizing the probe ends to the target sequence under hybridizing conditions; b) covalently connecting the ends of the hybridized probe with each other to form a circularized structure; c) washing under denaturating conditions. The method is characterized in that one end part of the probe is provided with a cleavable or dissociable detectable function, and the method comprises the further steps of: d) cleaving or dissociating said detectable function; e) separating probes with connected ends from probes with non-connected ends by washing under denaturing conditions; and f) detecting the presence and, if desired, location of the remaining probe as indicative of the presence of the target nucleic acid sequence. [0008]
    [0009] The detectable function can be cleavable by being connected to the remainder of the probe via a cleavable site or linker located on the same probe end as the detectable function. [0009]
    [0010] A dissociable detectable function can be provided on a second padlock probe having two free nucleic acid end parts which are at least partially complementary to and capable of hybridizing to two at least substantially neighbouring regions of the first probe sequence. Such a second padlock probe can be added to the probe either before or after the probe has been reacted with the target sequence. It is also possible to provide the dissociable detectable function on the target-sequence specific probe if the second padlock probe is immobilized to a support. [0010]
    [0011] In one embodiment of the method, the padlock probe has two linear probe ends. One of the probe ends contains a detectable function which is capable of being either cleaved off or dissociated from the probe end. [0011]
    [0012] In another embodiment of the method, at least one of the probe ends of the padlock probe is branched, e.g. with up to ten branches or even more, and a cleavable or dissociable detectable function is provided on each of the branches or arms. The branch ends may be specific for the respective sequence variants to be distinguished in the assay, for instance to identify allelic sequence variants or to perform a quantitative comparison between similar sequences. Preferably, only one of the probe ends is branched, especially bifurcated. [0012]
    [0013] In the method according to the present invention, the covalent linking or connecting between two ends of a probe anchors a detectable signal. If no linking has ocurred, the signal will not be detected. Examples of preferred signals are fluorophores, radioisotopes, haptens, enzymes etc. [0013]
    [0014] The covalent connection of the probe ends to each other after hybridization to the target sequence may be performed by enzymatic, ribozyme-mediated or chemical ligation, preferably enzymatic ligation. [0014]
    [0015] Instead of letting the probe ends hybridize in juxtaposition to the target sequence, the probe may be designed to hybridize to the target molecule such that an interspace is left between the probe ends, and that at least one additional probe is provided which is designed to hybridize to the target molecule in this interspace, whereupon the hybridized probes are covalently interconnected. [0015]
    [0016] Optionally, the probe or probes are designed to hybridize to the target molecule to leave a small gap between adjacent probe ends. This gap or gaps are then filled by an extension reaction prior to covalently interconnecting the probe ends. [0016]
    [0017] The method of the invention may particularly be used for detecting, quantifying and distinguishing between sequence variants with regard to one or several target sequences in a sample. Examples of applications include distinction between normal and mutated sequence variants, associated with disease, genetic linkage analysis of biallelic markers, and quantification of gene expression in a tissue sample. [0017]
    [0018] In a second aspect of the invention, there is provided a kit for detecting a target nucleic acid sequence in a sample, comprising a) a padlock probe having two free nucleic acid end parts which are at least partially complementary to and capable of hybridizing to two at least substantially neighbouring regions of the target sequence; and b) a means for connecting the ends to each other after hybridization to the target sequence. The kit according to the invention is characterized in c) a cleavable or dissociable detectable function; and, optionally, d) a cleaving agent. [0018]
    [0019] In one embodiment of the kit, the padlock probe has two linear probe ends, one of the probe ends containing a detectable function which is cleavable or dissociable. [0019]
    [0020] In another embodiment of the kit, at least one of the two free nucleic acid end parts of the padlock probe is branched, e.g. with up to ten branches or even more, and each of the branches or arms is provided with a different detectable function. Preferably, only one of the probe ends is branched, especially bifurcated. [0020]
    [0021] In a third aspect, the present invention provides for use of the above kit for distinction between sequence-specific variants of nucleic acids, such as allele-specific variants. [0021]
    [0022] In a fourth aspect, there is provided a padlock probe having two free nucleic acid end parts which are at least partially complementary to and capable of hybridizing to two at least substantially neighbouring regions of the target sequence, and at least one cleavable or dissociable function on one of the end parts of the probe. [0022]
    [0023] In a fifth aspect there is provided a padlock probe having two free nucleic acid end parts, where at least one of the two end parts is branched. [0023] DETAILED DESCRIPTION OF THE INVENTION
    [0024] The invention will now be described in more detail below in association with the accompanying drawings, in which [0024]
    [0025] FIG. 1 shows a monospecific cleavable detectable probe; [0025]
    [0026] FIG. 2 shows a monospecific dissociable detectable probe; [0026]
    [0027] FIG. 3 shows a bispecific cleavable detectable probe having differentially labelled sequence variant-specific and cleavable probe branches; [0027]
    [0028] FIG. 4 shows a bispecific dissociable detectable probe having differentially labelled sequence variant-specific secondary padlock probes, attached to sequence variant-specific branches; [0028]
    [0029] FIG. 5 shows a variant of a monospecific dissociable detectable probe where the detectable function is provided on the target-sequence specific probe; [0029]
    [0030] FIG. 6 shows the DNA sequences of a cleavable padlock probe and a complementary target sequence; and [0030]
    [0031] FIG. 7 shows the two DNA sequences in FIG. 6 together with the DNA sequence of a padlock probe complementary to the back-piece of the cleavable padlock probe. [0031]
    [0032] In FIG. 1, two probes terminating with free 3′and 5′ends, respectively, are immobilized together on a support S via a solid phase anchor A. One of the arms also includes a breakable link to the support in the form of a cleavable linker B, and, farther away from the support, a detectable function C such as a fluorophore. Examples of cleavable links and cleaving agents include disulphides, cleavable by reducing agents such as dithiothreitol, deoxyuridine residues, cleavable by uracil DNA glycosylase; peptide residues cleavable by peptidases and nucleotide sequences susceptible to cleavage by endonucleases. [0032]
    [0033] As an alternative to a support-bound format, it is possible to perform the hybridization-ligation reactions in solution, followed by an immobilization or separation reaction. [0033]
    [0034] If the two ends hybridize in juxtapositon on a target sequence, then they can become joined by an act of template-dependent ligation and thereby catenated to the target sequence as described in more detail in the above-mentioned WO 95/22623 (the disclosure of which is incorporated herein by reference). After the hybridization-ligation reaction, the cleavable linker is broken and the support is washed vigorously. Any remaining detectable group indicates that this has become joined to the support via the other probe arm. The probe thus functions as a logic “OR” gate, giving a positive answer as long as one or both of the links to the support are intact. [0034]
    [0035] In FIG. 2, the probes are constructed such that a secondary, detectable padlock probe D is allowed to circularize around the back-piece of a specific target detection padlock probe, bound to the support. If and only if this specific probe interacts with its target and is cyclized, then the detectable padlock probe will remain bound to the support after denaturing washes. [0035]
    [0036] If the probes are used for distinction of sequence variants, such as allele distinction reactions, then the detection probes can be designed as shown in FIGS. 3 and 4 to include a single 3′end and at the other end branching into two allele-specific 5′ends (or the other way around). In this design the sequence variant-specific probe segments can be designed to hybridize with lesser stability and they each have distinct cleavable, C′, C″, or dissociable detectable, C′, D′, C″, D″, functions. In this manner all target sequences can give rise to a signal but only from that sequence variant-specific probe that hybridizes and ligates the best. [0036]
    [0037] FIG. 5 shows an alternative embodiment of monospecific dissociable detectable probe to that shown in FIG. 2. While in FIG. 2, the target-sequence specific probe is immobilized and linked to the non-specific signal-generating padlock probe, D, the embodiment shown in FIG. 5 has the non-specific probe, E, immobilized and the detectable probe F is also target-sequence specific. [0037]
    [0038] While in FIGS. [0038] 1 to 5 the cleavable linker and the detectable function are shown provided on the 5′end arm or arms, the 3′and 5′ends may, of course, be reversed.
    [0039] Assays of the above type suffer no risk of crosstalk with increasing probe numbers as only intramolecular reactions are possible or detectable, extreme background reduction is possible through denaturing washes allowing convenient detection of thousands or less of target molecules, and excellent allele-distinction is obtained through the (competitive) ligation reactions. [0039]
    [0040] The methods of the invention can be be performed on immobilized target sequences, such as metaphase chromosomes. Following the ligation and washes at or above stringency, the probes are opened and the reaction washed resulting in the disappearance of free ends, but ends connected via hybridization retain their binding with the target sequence. [0040]
    [0041] While conventional linear hybridization probe arrays lack the specificity and background-reduction possibility required to analyze complex DNA samples, probes according to the invention avoid both of these limitations. However, one important difficulty of using complex samples as templates remain, viz. it is important to arrange the assay so that a DNA sample (preferably sheared or otherwise reduced in average size) is brought in close contact with all positions in a probe array. For this reason, one-dimensional probe arrays are envisioned for this purpose. These could be separate segments of channels or tubes through which the DNA sample is serially passed. It is also possible to use the principle of “stacking and sectioning” previously described in the international patent application WO 96/17246 (the disclosure of which is incorporated herein by reference) to create one-dimensional probe arrays of this type. [0041]
    [0042] The following non-limiting Examples illustrate the invention further. [0042] EXAMPLE 1 Detection Principle (FIG. 1)
    [0043] The detection principle is based upon that described above with regard to FIG. 1. A padlock probe of a defined specificity (below to Factor V) is synthesized with a few thymine (T) bases replaced by uracil (U) bases and is covalently immobilized to a surface or immobilized via biotin to a streptavidin-coated surface. Beyond the coupling site to the surface the padlock probe has a detectable tag, e.g. a fluorophore, and the uracil-containing part. The padlock probe is hybridized and ligated to its template and treated with the enzyme uracil DNA glycosylase (UDG). UDG cleaves off the uracil bases from the padlock probe to leave the phosphodiester bond. This abasic binding is unstable and is easily broken by heat, basic pH or Exonuclease III. If ligation has taken place, the tag signal will remain after wash, but if no ligation has taken place, the signal tag may be washed away since that part of the padlock probe is no longer connected to the rest of the probe and is thereby not attached to the surface. [0043]
    [0044] UDG-Cleavage of U-Containing DNA (In Solution) [0044]
    [0045] 0.1 pmole of 92-mer padlock probe to Factor V (Padlock FV, FIG. 6), [0045] 32P-labelled (73,000 cpm) at the 5′-end, was ligated to 1 pmole of PCR amplified Factor V oligonucleotide (Oligo FV, FIG. 6), using 5 units of T4 DNA ligase at 37°C. for 30 min. After ethanol precipitation, the sample was dissolved in UDG buffer and treated with 2 units of UDG at 37°C. for 30 min. The solution was then heat-treated at 65°C. for 10 min. and analyzed by 15% polyacrylamide gel electrophoresis (PAGE), 7 M urea, 0.5×TBE. The analysis showed that UDG cleavage produced four smaller fragments of the expected sizes, 20, 23, 26 and 29 nt, respectively. EXAMPLE 2 Detection Principle (FIG. 2)
    [0046] The detection principle is based upon that described above with regard to FIG. 2. Two different padlock probes A and B are used. One probe A has specificity to a template (below Factor V) and also exhibits a back-piece sequence which is complementary to the other probe B. Padlock probe B is tagged, e.g. with a fluorophore. Below it is demonstrated that (i) padlock probe A can be circularized in the ligation to its template consisting of a complementary oligonucleotide; (ii) padlock probe B can be circularized to padlock probe A; and (iii) padlock probes A and B can be circularized in the ligation to template. [0046]
    [0047] (i) Circularization of Padlock Probe A in Ligation to Complementary Oligonucleotide [0047]
    [0048] 0.1 pmole of 92-mer padlock probe to Factor V (Padlock FV, FIG. 7) described in Example 1, padlock probe A, and 1.35 pmole of Factor V oligonucleotide (Oligo FV, FIG. 7) complementary to padlock probe A was ligated by 6 units of T4 DNA ligase at 37°C. for 30 min. The enzyme was then heat-inactivated at 60°C. for 10 min. A control reaction was performed without ligase. PAGE as in Example 1 showed that a catenated complex of padlock probe A and the complementary oligonucleotide was obtained. [0048]
    [0049] (ii) Circularization of Padlock Probe B to Padlock Probe A [0049]
    [0050] 0.1 pmole of padlock probe A and 0.1 pmole of a padlock probe complementary to the back-piece of padlock probe A (Padlock αFV, FIG. 7), padlock probe B, were ligated as in (i) above. A control reaction was performed without ligase. PAGE as in Example 1 showed that a catenated complex of the two padlock probes A and B was obtained. [0050]
    [0051] (iii) Circularization of Padlock Probe A to Padlock Probe B and Oligonucleotide [0051]
    [0052] 0.1 pmole of each of the padlock probes A and B and 1.35 pmole of Factor V oligonucleotide were ligated as in (i) above. A control reaction was performed without ligase. PAGE as in Example 1 showed that a catenated complex of the two padlock probes and oligo FV was obtained. [0052]
    [0053] The invention is, of course, not restricted to the embodiments specifically described above and shown in the drawings, but many modifications and changes can be made within the scope of the present inventive concept as defined in the following claims. [0053]
    权利要求:
    Claims (21)
    [1" id="US-20010007742-A1-CLM-00001] 1. A method of detecting a target nucleic acid sequence in a sample by contacting the sample with a detectable probe to hybridize the probe to the target sequence, and detecting the hybridized probe, said probe having two free nucleic acid end parts which are at least partially complementary to and capable of hybridizing to two at least substantially neighbouring regions of the target sequence, comprising the following steps:
    a) hybridizing the probe ends to the target sequence under hybridizing conditions;
    b) covalently connecting the ends of the hybridized probe with each other to form a circularized structure;
    c) washing under denaturating conditions;
    characterized in that the probe is provided with a cleavable or dissociable detectable function, and the method comprises the further steps of:
    d) cleaving or dissociating said detectable function;
    e) separating probes with connected ends from probes with non-connected ends by washing under denaturing conditions; and
    f) detecting the presence and, if desired, location of the remaining probe as indicative of the presence of the target nucleic acid sequence.
    [2" id="US-20010007742-A1-CLM-00002] 2. The method according to
    claim 1 , characterized in that said detectable function is cleavable by cleaving a cleavable linker located on the same probe end as the detectable function.
    [3" id="US-20010007742-A1-CLM-00003] 3. The method according to
    claim 1 or
    2 , characterized in that one or both of the probe ends have at least two branches, preferably with differential sequence specificities, and that a detectable function is provided on each of the branches on one end part of the probe, the detectable functions preferably being different and distinguishable from each other.
    [4" id="US-20010007742-A1-CLM-00004] 4. The method according to
    claim 3 , characterized in that one probe end is linear and the other probe end is branched, preferably bifurcated.
    [5" id="US-20010007742-A1-CLM-00005] 5. The method according to
    claim 1 ,
    3 or 4, characterized in that said detectable function is dissociable by being provided on a further circularizable probe hybridizing to said target-specific probe.
    [6" id="US-20010007742-A1-CLM-00006] 6. The method according to
    claim 1 ,
    3 or 4, characterized in that said detectable function is dissociable by being provided on said target-specific probe hybridizing to a further circularizable probe.
    [7" id="US-20010007742-A1-CLM-00007] 7. The method according to any one of the preceding claims, characterized in that said target-specific probe is designed to hybridize to the target molecule to leave an interspace between the probe ends, that at least one additional probe is provided which is designed to hybridize to the target molecule in said interspace, and that the hybridized probes are covalently interconnected.
    [8" id="US-20010007742-A1-CLM-00008] 8. The method according to any one of the preceding claims, characterized in that said target-specific probe or probes are designed to hybridize to the target molecule to leave a small gap between adjacent probe ends, and that said gap or gaps are filled by an extension reaction prior to covalently interconnecting the probe ends.
    [9" id="US-20010007742-A1-CLM-00009] 9. The method according to any one of the preceding claims, characterized in that said covalent connection of the probe ends is performed by enzymatic, ribozyme-mediated or chemical ligation, preferably enzymatic ligation.
    [10" id="US-20010007742-A1-CLM-00010] 10. The method according to any one of the preceding claims, characterized in that said target molecule is a DNA or RNA sequence.
    [11" id="US-20010007742-A1-CLM-00011] 11. The method according to any one of the preceding claims, characterized in that probe or probes are oligonucleotides.
    [12" id="US-20010007742-A1-CLM-00012] 12. The method according to any one of the preceding claims, characterized in that said probe or probes are immobilized to a solid phase.
    [13" id="US-20010007742-A1-CLM-00013] 13. The method according to any of the claims 1-10, characterized in that said target sequence is immobilized to a solid phase.
    [14" id="US-20010007742-A1-CLM-00014] 14. A kit for detecting a target nucleic acid sequence in a sample, comprising
    a) a probe having two free nucleic acid end parts which are at least partially complementary to and capable of hybridizing to two at least substantially neighbouring regions of the target sequence;
    b) a means for connecting the ends to each other after hybridization to the target sequence;
    characterized in
    c) a cleavable of dissociable detectable function; and, optionally,
    d) a cleaving agent.
    [15" id="US-20010007742-A1-CLM-00015] 15. The kit according to
    claim 14 , characterized in that the detectable function is a fluorophore, radiosiotope, hapten or enzyme.
    [16" id="US-20010007742-A1-CLM-00016] 16. The kit according to
    claim 14 or
    15 , characterized in that one or both of the two free nucleic acid end parts of the probe have at least two branches, preferably with differential sequence specificities, and that each of the branches on one end part of the probe are provided with different detectable functions.
    [17" id="US-20010007742-A1-CLM-00017] 17. The kit according to
    claim 16 , characterized in that one probe end is linear and the other probe end is branched, preferably bifurcated.
    [18" id="US-20010007742-A1-CLM-00018] 18. Use of the kit according to any one of
    claims 14 to
    17 for distinction between sequence specific variants of nucleic acids.
    [19" id="US-20010007742-A1-CLM-00019] 19. A circularizable probe having two free nucleic acid end parts which are at least partially complementary to and capable of hybridizing to two at least substantially neighbouring regions of a target sequence, characterized in that the probe has a cleavable or dissociable detectable function on one of said end parts.
    [20" id="US-20010007742-A1-CLM-00020] 20. The probe according to
    claim 19 , characterized in that one or both of the two free nucleic acid end parts of the probe have at least two branches, preferably with differential sequence specificities, and that each of the branches on one end part of the probe are provided with different detectable functions.
    [21" id="US-20010007742-A1-CLM-00021] 21. A circularizable probe having two free nucleic acid end parts which are at least partially complementary to and capable of hybridizing to two at least substantially neighbouring regions of a target sequence, characterized in that one or both of the two free nucleic acid end parts of the probe are branched, especially bifurcated.
    类似技术:
    公开号 | 公开日 | 专利标题
    EP0951565B1|2003-03-05|Improved probing of specific nucleic acids
    US7914989B2|2011-03-29|Capture moieties for nucleic acids and uses thereof
    US7846693B2|2010-12-07|Nucleic acid detection assay
    US5770365A|1998-06-23|Nucleic acid capture moieties
    AU754849B2|2002-11-28|DNA polymorphism identity determination using flow cytometry
    EP1090138A1|2001-04-11|Nucleotide detection method
    JP2004501615A|2004-01-22|Degradable nucleic acid probe and nucleic acid detection method
    JP2004520812A|2004-07-15|Methods for determining alleles
    WO2002024955A2|2002-03-28|Detection of unlabeled hybridized dna and rna using restriction enzyme digestion
    US6020132A|2000-02-01|Method of analysis using signal amplification
    AU772995B2|2004-05-13|Methods of synthesizing polynucleotides by ligation of multiple oligomers
    WO2000029624A2|2000-05-25|Methods and compositions for detection of nucleic acid sequences and signal amplification
    JP2003522527A|2003-07-29|Single nucleotide polymorphism detection
    EP2561098B1|2015-09-09|Tethered enzyme mediated nucleic acid detection
    AU2004270756B2|2006-11-16|Nucleic acid detection assay
    CA2309861A1|1999-05-20|Methods and compositions for detection of specific nucleotide sequences
    WO2000009738A9|2000-05-18|Rolling circle-based analysis of polynucleotide sequence
    US20040203005A1|2004-10-14|Dual hybridization of complex nucleic acid samples for sequencing and single-nucleotide polymorphism identification
    同族专利:
    公开号 | 公开日
    EP0951565A1|1999-10-27|
    US7351528B2|2008-04-01|
    EP0951565B1|2003-03-05|
    DE69719557D1|2003-04-10|
    AT233826T|2003-03-15|
    SE9601676D0|1996-04-30|
    WO1997041254A1|1997-11-06|
    JP2000508920A|2000-07-18|
    CA2252817C|2009-07-07|
    CA2252817A1|1997-11-06|
    DE69719557T2|2004-02-26|
    US20020102592A1|2002-08-01|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    US20040191816A1|1992-08-04|2004-09-30|Replicon, Inc.|In vitro amplification of nucleic acid molecules via circular replicons|
    US20080012990A1|2006-07-13|2008-01-17|Hirokazu Kitamura|Portable device|
    US20080305535A1|1992-08-04|2008-12-11|Replicon, Inc.|In vitro amplification of nucleic acid molecules via circular replicons|
    US8812422B2|2012-04-09|2014-08-19|Good Start Genetics, Inc.|Variant database|
    US9115387B2|2013-03-14|2015-08-25|Good Start Genetics, Inc.|Methods for analyzing nucleic acids|
    US9228233B2|2011-10-17|2016-01-05|Good Start Genetics, Inc.|Analysis methods|
    US9535920B2|2013-06-03|2017-01-03|Good Start Genetics, Inc.|Methods and systems for storing sequence read data|
    US10066259B2|2015-01-06|2018-09-04|Good Start Genetics, Inc.|Screening for structural variants|
    US10227635B2|2012-04-16|2019-03-12|Molecular Loop Biosolutions, Llc|Capture reactions|
    US10429399B2|2014-09-24|2019-10-01|Good Start Genetics, Inc.|Process control for increased robustness of genetic assays|
    US10604799B2|2012-04-04|2020-03-31|Molecular Loop Biosolutions, Llc|Sequence assembly|
    US10851414B2|2013-10-18|2020-12-01|Good Start Genetics, Inc.|Methods for determining carrier status|
    US11041203B2|2013-10-18|2021-06-22|Molecular Loop Biosolutions, Inc.|Methods for assessing a genomic region of a subject|
    US11041851B2|2010-12-23|2021-06-22|Molecular Loop Biosciences, Inc.|Methods for maintaining the integrity and identification of a nucleic acid template in a multiplex sequencing reaction|
    US11053548B2|2014-05-12|2021-07-06|Good Start Genetics, Inc.|Methods for detecting aneuploidy|US5124246A|1987-10-15|1992-06-23|Chiron Corporation|Nucleic acid multimers and amplified nucleic acid hybridization assays using same|
    US5427930A|1990-01-26|1995-06-27|Abbott Laboratories|Amplification of target nucleic acids using gap filling ligase chain reaction|
    SE9400522D0|1994-02-16|1994-02-16|Ulf Landegren|Method and reagent for detecting specific nucleotide sequences|
    US5643724A|1994-06-06|1997-07-01|Roche Molecular Systems, Inc.|Methods and reagents for Glycophorin A typing|
    GB9414934D0|1994-07-25|1994-09-14|Raggio Italgene Spa|Method and reagents for the detection of target nuceic acid sequences|
    EP0843735B2|1995-07-11|2006-12-27|Forfas |Glycosylase mediated detection of known nucleotide sequences|AU2003295745A1|2002-11-19|2004-06-15|Applera Corporation|Polynucleotide sequence detection assays|
    EP1572974A2|2002-11-19|2005-09-14|Applera Corporation|Polynucleotide sequence detection assays and analysis|
    US8168777B2|2004-04-29|2012-05-01|Human Genetic Signatures Pty. Ltd.|Bisulphite reagent treatment of nucleic acid|
    DE602004028478D1|2003-06-17|2010-09-16|Human Genetic Signatures Pty|PROCESS FOR GENOMA PLIFICATION|
    AT419394T|2003-09-04|2009-01-15|Human Genetic Signatures Pty|NUCLEIC DETECTION TEST|
    WO2005113804A1|2004-05-20|2005-12-01|Trillion Genomics Limited|Use of mass labelled probes to detect target nucleic acids using mass spectrometry|
    DK1794173T3|2004-09-10|2010-10-25|Human Genetic Signatures Pty|Amplification blocks containing intercalating nucleic acidscontaining intercalating pseudonucleotides |
    EP1828411B1|2004-12-03|2012-11-07|Human Genetic Signatures PTY Ltd|Methods for simplifying microbial nucleic acids by chemical modification of cytosines|
    CA2609218C|2005-05-26|2016-10-11|Human Genetic Signatures Pty Ltd|Isothermal strand displacement amplification using primers containing a non-regular base|
    CN101292046B|2005-09-14|2013-03-13|人类遗传标记控股有限公司|Assay for a health state|
    WO2009067743A1|2007-11-27|2009-06-04|Human Genetic Signatures Pty Ltd|Enzymes for amplification and copying bisulphite modified nucleic acids|
    WO2009121021A1|2008-03-28|2009-10-01|Life Technologies Corporation|Degradable arrays for preventing reuse|
    EP2438442B1|2008-12-01|2017-08-09|Laboratory Corporation of America Holdings|Methods and assays for measuring p95 and/or p95 complexes in a sample and antibodies specific for p95|
    EP2387717B1|2009-01-15|2014-12-10|Laboratory Corporation of America Holdings|Methods of determining patient response by measurement of her-2 expression|
    ES2535723T3|2009-01-15|2015-05-14|Laboratory Corporation Of America Holdings|Methods for determining the patient's response by measuring Her-3|
    JP2013511991A|2009-11-25|2013-04-11|クアンタライフ，インコーポレイテッド|Methods and compositions for detecting genetic material|
    EP3483285B1|2011-02-09|2021-07-14|Bio-Rad Laboratories, Inc.|Analysis of nucleic acids|
    CN113151404A|2011-02-15|2021-07-23|莱卡生物系统纽卡斯尔有限责任公司|Method for in situ detection of localization of MRNA|
    US9556473B2|2011-02-15|2017-01-31|Leica Biosystems Newcastle Ltd|Methods for identifying nucleic acid sequences|
    US8759036B2|2011-03-21|2014-06-24|Affymetrix, Inc.|Methods for synthesizing pools of probes|
    US8932819B2|2011-07-06|2015-01-13|Affymetrix, Inc.|Assays for affinity profiling of nucleic acid binding proteins|
    AU2011376698B2|2011-09-07|2014-07-17|Human Genetic Signatures Pty Ltd|Molecular detection assay|
    CN110308272A|2013-03-13|2019-10-08|中尺度技术有限责任公司|Improved measuring method|
    US10114015B2|2013-03-13|2018-10-30|Meso Scale Technologies, Llc.|Assay methods|
    KR102134168B1|2013-03-15|2020-07-15|루브리졸 어드밴스드 머티어리얼스, 인코포레이티드|Heavy metal free cpvc compositions|
    EP3024948B1|2013-07-25|2020-01-15|Bio-rad Laboratories, Inc.|Genetic assays for detecting viral recombination rate|
    WO2015175856A1|2014-05-15|2015-11-19|Meso Scale Technologies, Llc.|Improved assay methods|
    KR20170018346A|2014-06-13|2017-02-17|큐-리네아 에이비|Method for detecting and characterising a microorganism|
    EP3209798A4|2014-10-23|2018-03-14|Ricardo Mancebo|Reagents and methods for isothermal chain reaction|
    GB201507026D0|2015-04-24|2015-06-10|Linea Ab Q|Medical sample transportation container|
    CN108350500A|2015-07-29|2018-07-31|普罗格尼迪公司|Nucleic acid for detecting chromosome abnormality and method|
    WO2017087560A1|2015-11-16|2017-05-26|Progenity, Inc.|Nucleic acids and methods for detecting methylation status|
    CA3056650A1|2017-03-30|2018-10-04|Pioneer Hi-Bred International, Inc.|Methods of identifying and characterizing gene editing variations in nucleic acids|
    EP3931201A1|2019-03-01|2022-01-05|Meso Scale Technologies, LLC|Electrochemiluminescent labeled probes for use in immunoassay methods, methods using such and kits comprising same|
    WO2020206170A1|2019-04-02|2020-10-08|Progenity, Inc.|Methods, systems, and compositions for counting nucleic acid molecules|
    WO2021252800A1|2020-06-11|2021-12-16|Nautilus Biotechnology, Inc.|Methods and systems for computational decoding of biological, chemical, and physical entities|
    法律状态:
    2003-03-20| STCB| Information on status: application discontinuation|Free format text: EXPRESSLY ABANDONED -- DURING EXAMINATION |
    优先权:
    申请号 | 申请日 | 专利标题
    SE9601676-1||1996-04-30||
    SE9601676A|SE9601676D0|1996-04-30|1996-04-30|Improved probing of specific mucleic acids|US10/029,913| US7351528B2|1996-04-30|2001-12-31|Probing of specific nucleic acids|
    [返回顶部]